| | Report | Presentation | Webcast |
| December 2, 2021Presentation at Stora Aktiedagen Stockholm | | | |
| December 2, 2021Oasmia - Presentation Erik Penser Bank | | | |
| November 18, 2021Interim Report January – September 2021 | | | |
| October 21, 2021Interview Erik Penser Bank | | | |
| September 29, 2021Naventus LifeScience Summit | | | |
| September 7, 2021Presentation at Aktiedagen Stockholm | | | |
| August 19, 2021Interim Report January – June 2021 | | | |
| June 11, 2021Aktiespararna: Interview with Oasmia Pharmaceutical | | | |
| May 27, 2021Interim Report January – March 2021 | | | |
| April 29, 2021Annual Report 2020 | | | |
| April 12, 2021Cantrixil abstract from Final Phase I Data at the 2021 AACR Annual Meeting | | | |
| March 21, 2021BioEurope Spring, Virtual | | | |
| March 11, 2021Sachs 14th Annual European Life Sciences CEO Forum, Virtual | | | |
| March 1, 2021Oasmia acquires global development and commercialization rights for Cantrixil | | | |
| February 19, 2021Year-end report 2020 | | | |
| January 19, 2021SEB Digital Healthcare Seminar Presentation | | | |
